BR0011640A - ácidos aldÈnicos de oligossacarìdeo e seu uso tópico - Google Patents

ácidos aldÈnicos de oligossacarìdeo e seu uso tópico

Info

Publication number
BR0011640A
BR0011640A BR0011640-8A BR0011640A BR0011640A BR 0011640 A BR0011640 A BR 0011640A BR 0011640 A BR0011640 A BR 0011640A BR 0011640 A BR0011640 A BR 0011640A
Authority
BR
Brazil
Prior art keywords
well
acids
prevention
treatment
oligosaccharide
Prior art date
Application number
BR0011640-8A
Other languages
English (en)
Other versions
BR0011640B1 (pt
BRPI0011640B8 (pt
Inventor
Ruey J Yu
Eugene J Van Scott
Original Assignee
Ruey J Yu
Eugene J Van Scott
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ruey J Yu, Eugene J Van Scott filed Critical Ruey J Yu
Publication of BR0011640A publication Critical patent/BR0011640A/pt
Publication of BR0011640B1 publication Critical patent/BR0011640B1/pt
Publication of BRPI0011640B8 publication Critical patent/BRPI0011640B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0212—Face masks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

"áCIDOS ALDÈNICOS DE OLIGOSSACARìDEO E SEU USO TóPICO". Composições compreendendo ácidos aldónicos de oligossacarídeo soa úteis par cuidado geral, bem como para tratamento e prevenção de vários distúrbios dermatológicos e condições cosméticas, incluindo os associados com envelhecimento intrínseco e/ou extrínseco, bem como com alterações ou dano ocasionados por fatores extrínsecos; cuidado geral, bem como tratamento e prevenção de doenças e condições da mucosa oral e vaginal, para cuidado oral geral, bem como no tratamento e prevenção de doenças da boca e gengivas, e para a cura de ferimentos da pele. As composições compreendendo ácidos aldónicos de oligossacarídeo podem ainda compreender um agente cosmético, farmacêutico ou outro agente tópico para intensificar ou criar efeitos sinérgicos.
BRPI0011640A 1999-06-30 2000-06-28 ácidos aldônicos de oligossacarídeo e seu uso tópico BRPI0011640B8 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US14126499P 1999-06-30 1999-06-30
US60/141,264 1999-06-30
US09/487,228 US6335023B1 (en) 1999-06-30 2000-01-19 Oligosaccharide aldonic acids and their topical use
US09/487,228 2000-01-19
PCT/US2000/016301 WO2001001932A2 (en) 1999-06-30 2000-06-28 Oligosaccharide aldonic acids and their topical use

Publications (3)

Publication Number Publication Date
BR0011640A true BR0011640A (pt) 2002-05-14
BR0011640B1 BR0011640B1 (pt) 2014-07-29
BRPI0011640B8 BRPI0011640B8 (pt) 2021-05-25

Family

ID=26838940

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0011640A BRPI0011640B8 (pt) 1999-06-30 2000-06-28 ácidos aldônicos de oligossacarídeo e seu uso tópico

Country Status (16)

Country Link
US (2) US6335023B1 (pt)
EP (1) EP1227820B1 (pt)
JP (3) JP4326737B2 (pt)
CN (1) CN1635864B (pt)
AT (1) ATE323498T1 (pt)
AU (1) AU775620B2 (pt)
BR (1) BRPI0011640B8 (pt)
CA (1) CA2373852C (pt)
CY (1) CY1105407T1 (pt)
DE (1) DE60027455T2 (pt)
DK (1) DK1227820T3 (pt)
ES (1) ES2262529T3 (pt)
HK (1) HK1048764B (pt)
MX (1) MX249762B (pt)
PT (1) PT1227820E (pt)
WO (1) WO2001001932A2 (pt)

Families Citing this family (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19646392A1 (de) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
FR2775976B1 (fr) * 1998-03-10 2000-06-02 Fabre Pierre Dermo Cosmetique Composition pharmaceutique ou cosmetique contenant un precurseur d'actif hydrolysable par la glucocerebrosidase
CA2360865A1 (en) * 1999-02-03 2000-08-10 Biogal Gyogyszergyar Rt. Process for the preparation of pseudomonic acid a antibiotic by microbiological method
US6242491B1 (en) 1999-06-25 2001-06-05 Rima Kaddurah-Daouk Use of creatine or creatine compounds for skin preservation
US6335023B1 (en) * 1999-06-30 2002-01-01 Ruey J. Yu Oligosaccharide aldonic acids and their topical use
US7452545B2 (en) * 2001-11-13 2008-11-18 Yu Ruey J Oligosaccharide aldonic acids and their topical use
DE10114561A1 (de) † 2001-03-24 2002-09-26 Wella Ag Verwendung von Mitteln enthaltend Kreatin, Kreatin und/oder deren Derivaten zur Verstärkung und Strukturverbesserung von keratinischen Fasern
AU2002314847A1 (en) 2001-05-31 2002-12-09 Upsher-Smith Laboratories, Inc. Dermatological compositions and methods comprising alpha-hydroxy acids or derivatives
CZ200467A3 (cs) * 2001-06-21 2004-10-13 Biogalágyogyszergyarárt Metabolicky řízený způsob fermentace pro výrobu pseudomonové kyseliny
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
FR2830449B1 (fr) * 2001-10-05 2004-04-23 Fabre Pierre Dermo Cosmetique Utilisation du tazarotene pour la preparation d'un vernis a ongles pour le traitement et/ou la prevention du psoriasis et un vernis a ongles le contenant
US6824786B2 (en) * 2001-11-27 2004-11-30 Ruey J. Yu Compositions comprising phenyl-glycine derivatives
PL371263A1 (en) 2001-12-28 2005-06-13 Biogal Gyogyszergyar Rt Processes for preparing crystalline and amorphous mupirocin calcium
US6869598B2 (en) * 2002-03-22 2005-03-22 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Stabilization of sunscreens in cosmetic compositions
DE10214507A1 (de) * 2002-04-02 2003-10-16 Beiersdorf Ag Verwendung von Acarbose und deren Derivaten zur Behandlung und Prophylaxe degenerativer Hautzustände
WO2003086291A2 (en) * 2002-04-10 2003-10-23 Yu Ruey J Urea compositions
US7622117B2 (en) * 2002-04-17 2009-11-24 Dynamis Therapeutics, Inc. 3-deoxyglucosone and skin
US6573301B1 (en) * 2002-04-23 2003-06-03 Bradley Pharmaceuticals, Inc. Carbamide peroxide compositions for the treatment of dermatological disorders and methods for their use
WO2003097573A1 (en) * 2002-05-16 2003-11-27 Sepracor, Inc. Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
US7780992B2 (en) * 2002-12-08 2010-08-24 Tareq Abduljalil Albahri Antiviral medicament
US20040151716A1 (en) * 2003-02-03 2004-08-05 Hamer Richard A. Material and method for treating microbial mediated dermatological conditions
US20040214215A1 (en) * 2003-03-07 2004-10-28 Yu Ruey J. Bioavailability and improved delivery of alkaline pharmaceutical drugs
MXPA05009694A (es) * 2003-03-13 2005-10-20 3M Innovative Properties Co Metodos para mejorar la calidad de la piel.
US20040220259A1 (en) * 2003-04-04 2004-11-04 Yu Ruey J. Topical treatment of dermatological disorders associated with reactive or dilated blood vessels
US7521459B2 (en) * 2003-07-28 2009-04-21 Metabeauty Inc. Method for treating damaged skin
US20060229258A1 (en) * 2003-07-30 2006-10-12 Daniela Serikaku Steroidal compositions containing hydroxycarboxylic acids and methods of using the same
US20050095215A1 (en) * 2003-11-03 2005-05-05 Popp Karl F. Antimicrobial shampoo compositions
EP1706128B1 (en) 2003-12-08 2010-07-21 CPEX Pharmaceuticals, Inc. Pharmaceutical compositions and methods for insulin treatment
US7812049B2 (en) * 2004-01-22 2010-10-12 Vicept Therapeutics, Inc. Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α1-adrenoceptor agonists
WO2005084627A1 (en) * 2004-03-01 2005-09-15 University Of Iowa Research Foundation Alcohol-free chlorhexidine compositions
US20050196418A1 (en) * 2004-03-04 2005-09-08 Yu Ruey J. Bioavailability and improved delivery of alkaline pharmaceutical drugs
CA2560984A1 (en) * 2004-06-01 2005-12-15 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Process for preparation of amorphous form of a drug
US7704522B2 (en) * 2004-09-08 2010-04-27 Clyde Morgan Topical medicament
US8835413B2 (en) 2004-10-20 2014-09-16 Endorecherche, Inc. Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 cGMP phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women
TW200621306A (en) * 2004-10-22 2006-07-01 Dynamis Therapeutics Inc Dermal delivery of n-methyl-glucamine and n-methyl-glucamine compounds
US20060193922A1 (en) * 2005-02-25 2006-08-31 Natalia Neikrug Compositions and methods for the treatment of acne
US7964582B2 (en) * 2005-03-21 2011-06-21 J&J Consumer Companies, Inc. Methods of treating skin and mucosal tissue atrophy using compositions including tensioning polymers
US8277780B2 (en) * 2005-05-27 2012-10-02 Taro Pharmaceutical North America, Inc. Stable liquid desoximethasone compositions with reduced oxidized impurity
US20070071705A1 (en) * 2005-09-29 2007-03-29 De Oliveira Monica A M Topical anti-microbial compositions
US8168206B1 (en) 2005-10-06 2012-05-01 Allergan, Inc. Animal protein-free pharmaceutical compositions
US7709014B2 (en) * 2005-10-17 2010-05-04 Yu Ruey J Hydroxy-oligocarboxylic esters: effects on nerve and use for cutaneous and mucocutaneous organs or sites
WO2007103687A2 (en) * 2006-03-01 2007-09-13 Tristrata, Inc. Composition and method for topical treatment of tar-responsive dermatological disorders
US7282224B1 (en) 2006-06-09 2007-10-16 Guthy-Renker Corporation Pain relief composition
US20080014252A1 (en) * 2006-07-14 2008-01-17 Delprete Keith Topical compositions with long lasting effect
US20080085331A1 (en) * 2006-10-06 2008-04-10 Gluskin Anna E Composition and method for raising blood glucose level
US20080107747A1 (en) * 2006-10-23 2008-05-08 Roederer Joy E Pain relief composition
US20090105196A1 (en) * 2007-06-22 2009-04-23 Belinda Tsao Nivaggioli Use of creatine compounds to treat dermatitis
US8268806B2 (en) 2007-08-10 2012-09-18 Endorecherche, Inc. Pharmaceutical compositions
EP2217725A2 (en) * 2007-11-08 2010-08-18 Interleukin Genetics, Inc. Diagnostics for aging-related dermatologic disorders
JP5670196B2 (ja) 2007-11-16 2015-02-18 バイセプト セラピューティクス、インク． 紫斑を治療する組成物および方法
US8754589B2 (en) * 2008-04-14 2014-06-17 Digtial Lumens Incorporated Power management unit with temperature protection
US10539311B2 (en) * 2008-04-14 2020-01-21 Digital Lumens Incorporated Sensor-based lighting methods, apparatus, and systems
US8823277B2 (en) * 2008-04-14 2014-09-02 Digital Lumens Incorporated Methods, systems, and apparatus for mapping a network of lighting fixtures with light module identification
US8805550B2 (en) * 2008-04-14 2014-08-12 Digital Lumens Incorporated Power management unit with power source arbitration
US8866408B2 (en) * 2008-04-14 2014-10-21 Digital Lumens Incorporated Methods, apparatus, and systems for automatic power adjustment based on energy demand information
WO2009129525A2 (en) * 2008-04-18 2009-10-22 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Antifungal and anti-cariogenic cellobio-oligosaccharides produced by dextransucrase
CN102088956A (zh) * 2008-05-09 2011-06-08 托马有限公司 氯胍用于治疗皮肤/粘膜疾病
BRPI0914865A2 (pt) * 2008-06-06 2015-11-03 Nutricia Nv uso de uma composição
US20110092493A1 (en) * 2008-09-24 2011-04-21 Clark Levi Dose-controlled transdermal promethazine compositions and methods of use
KR20110106346A (ko) * 2008-12-10 2011-09-28 알러간, 인코포레이티드 클로스트리디움 독소 약제학적 조성물
US8980840B2 (en) 2009-01-13 2015-03-17 Schepens Eye Research Institute Therapeutic modulation of vaginal epithelium boundary lubrication
US8954170B2 (en) * 2009-04-14 2015-02-10 Digital Lumens Incorporated Power management unit with multi-input arbitration
IT1397735B1 (it) * 2010-01-18 2013-01-24 Binda Composizione cosmetica ad attivita' idratante ed antiossidante.
US20120027876A1 (en) * 2010-07-27 2012-02-02 Sara Beth Ford Composition and Method for the Topical Treatment of Dermatitis
JP6057496B2 (ja) * 2010-12-24 2017-01-11 サンエイ糖化株式会社 歯牙エナメル質の再石灰化促進剤
US10202338B2 (en) * 2011-06-21 2019-02-12 Evologie Llc Topical compositions for the treatment of dermatological disorders
JP6222894B2 (ja) * 2012-03-30 2017-11-01 小林製薬株式会社 表皮肥厚促進剤
US9259343B2 (en) 2012-07-06 2016-02-16 Newman Technologies LLC Device for mitigating plantar fasciitis
US9089506B2 (en) * 2013-02-27 2015-07-28 Precision Dermatology, Inc. Stable, non-irritating topical formulations of hydroquinone
WO2015023926A1 (en) 2013-08-15 2015-02-19 Mary Kay Inc. Topical skin compositions for treating wrinkles
JP6305727B2 (ja) * 2013-10-31 2018-04-04 ポーラ化成工業株式会社 皮膚光老化防止用組成物
JP6580342B2 (ja) * 2014-02-28 2019-09-25 マルホ株式会社 トロポエラスチン発現促進剤およびエラスチン産生促進剤
BR112016023571B1 (pt) 2014-04-30 2020-12-01 Kimberly-Clark Worldwide, Inc. métodos para reduzir os sinais de envelhecimento da pele em um indivíduo, para aumentar a adipogênese da face e do corpo de um indivíduo e para aumentar a lipogênese da face e do corpo de um indivíduo
AU2014392626B2 (en) 2014-04-30 2020-07-02 Kimberly-Clark Worldwide, Inc. Topical compositions for stimulating adipogenesis and lipogenesis to reduce the signs of skin aging
AU2014392686B2 (en) 2014-04-30 2019-08-22 Kimberly-Clark Worldwide, Inc. Topical composition including a combination of extracts for reducing signs of skin aging
BR112016023890B1 (pt) 2014-04-30 2020-12-01 Kimberly-Clark Worldwide, Inc métodos para reduzir sinais de envelhecimento da pele, para aumentar a adipogênese da face e do corpo e para aumentar a lipogênese da face e do corpo
WO2015167535A1 (en) * 2014-04-30 2015-11-05 Kimberly-Clark Worldwide, Inc. Methods of reducing signs of skin aging using a combination of extracts
BR112016022734B1 (pt) 2014-04-30 2020-12-01 Kimberly-Clark Worldwide, Inc. método para redução do estresse oxidativo das células, método para redução da apoptose de células induzida pelo estresse oxidativo e método para redução do fotodano das células
EP4349414B1 (en) 2014-12-23 2025-10-15 Dyve Biosciences, Inc. Formulations for transdermal administration
JP2015221821A (ja) * 2015-08-11 2015-12-10 サンエイ糖化株式会社 歯牙エナメル質の再石灰化促進剤
US10933018B2 (en) 2015-10-30 2021-03-02 Timber Pharmaceuticals Llc Isotretinoin formulations and uses and methods thereof
CN105853275B (zh) * 2016-04-26 2018-10-02 上海波林丝生物科技有限公司 一种生发育发的自然植物组分的配方
GB2562270B (en) 2017-05-10 2020-07-01 Hyphens Pharma Pte Ltd Skin barrier composition
US10556133B2 (en) 2017-06-05 2020-02-11 Momentive Performance Materials Inc. Composition and method for strengthening hair fiber
EP3681479B1 (en) 2017-09-15 2024-01-31 Dyve Biosciences, Inc. Sodium bicarbonate for use in the treatment of gout and related disorders
US10786448B2 (en) 2018-01-18 2020-09-29 Christian Arnold Chewing gum composition comprising polyhexanide
KR102199678B1 (ko) * 2018-08-23 2021-01-07 주식회사 엘지생활건강 인간지방줄기세포의 분화 촉진용 조성물
CN111514161B (zh) * 2020-05-28 2021-05-04 江苏雪豹日化有限公司 一种抗口腔溃疡制剂及其应用
CN111690072B (zh) * 2020-06-05 2021-05-28 江南大学 一种棉织物用多醛酸抗皱整理剂的制备及其应用
KR102598193B1 (ko) * 2021-06-14 2023-11-06 대상 주식회사 효소적 산화를 이용한 말토비온산 제조방법
WO2023023884A1 (en) * 2021-08-23 2023-03-02 The Procter & Gamble Company Oral care compositions for gum health
MX2024001482A (es) * 2021-08-23 2024-02-27 Procter & Gamble Composiciones para el cuidado bucal para la salud de las encias.

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1772975A (en) 1925-06-20 1930-08-12 Firm C H Boehringer Sohn Chem Process for the production of antiseptic agents
US2118566A (en) 1935-08-29 1938-05-24 Miles Gilbert De Wayne Buffered cosmetic
US3227616A (en) 1961-07-03 1966-01-04 Warner Lambert Pharmaceutical Emulsions of cactus plant extract
US3689668A (en) 1967-10-18 1972-09-05 Emile Leon Piette Method of alleviating wrinkles on skin
SE325667B (pt) 1968-03-06 1970-07-06 Medisan Ab
GB1316971A (en) 1969-05-20 1973-05-16 Hayashibara Co Process for production of aldobionic acids and their salts
FR2072692A5 (pt) 1969-12-04 1971-09-24 Hayashibara Co
GB1388836A (en) 1971-06-01 1975-03-26 Medisan Ab Cosmetic compositions
US3879537A (en) 1973-09-04 1975-04-22 Scott Eugene J Van Treatment of ichthyosiform dermatoses
US3991184A (en) 1973-10-05 1976-11-09 Martin Kludas Agent for the care of skin
US4294852A (en) 1973-11-01 1981-10-13 Johnson & Johnson Skin treating compositions
US3988470A (en) 1974-02-25 1976-10-26 Scott Eugene J Van Treatment of palmar and plant disturbed keratosis
US3984566A (en) 1974-02-25 1976-10-05 Scott Eugene J Van Method of alleviating the symptoms of dandruff
ZA752066B (en) 1974-05-02 1976-03-31 Draco Ab Dermatologically active preparation
US4197316A (en) 1975-07-23 1980-04-08 Scott Eugene J Van Treatment of dry skin
US4021572A (en) 1975-07-23 1977-05-03 Scott Eugene J Van Prophylactic and therapeutic treatment of acne vulgaris utilizing lactamides and quaternary ammonium lactates
US4380549A (en) 1975-07-23 1983-04-19 Scott Eugene J Van Topical treatment of dry skin
US4363815A (en) 1975-07-23 1982-12-14 Yu Ruey J Alpha hydroxyacids, alpha ketoacids and their use in treating skin conditions
US4053630A (en) 1976-07-07 1977-10-11 Yu Ruey J Treatment of body odor and disturbed keratinization
BR7904612A (pt) 1978-07-24 1980-04-08 Unilever Nv Composicao cosmeticamente aceitavel para aplicacao topica,processo para preparar uma composicao,aplicador e processopara prover vantagem a pele
US4234599A (en) 1978-10-04 1980-11-18 Scott Eugene J Van Treatment of skin keratoses with α-hydroxy acids and related compounds
US4246261A (en) 1979-08-09 1981-01-20 Scott Eugene J Van Additives enhancing topical corticosteroid action
US4287214A (en) 1979-09-24 1981-09-01 Scott Eugene J Van Dithranol compositions stabilized with alpha hydroxyacids
AU548341B2 (en) 1982-02-02 1985-12-05 Unilever Plc Acne treatment composition
US4518789A (en) 1982-06-30 1985-05-21 Yu Ruey J Phenyl alpha-acyloxyacetamide derivatives and their therapeutic use
DE3239296A1 (de) 1982-10-23 1984-06-14 Henkel Kgaa Haarkosmetische mittel
US4608370A (en) 1985-03-04 1986-08-26 Aronsohn Richard B Skin formulation
DE3540175C2 (de) 1985-11-13 1997-03-27 Merck Patent Gmbh Dithranolhaltige pharmazeutische Zubereitung
US4929722A (en) 1986-06-06 1990-05-29 Union Carbide Chemicals And Plastics Company Inc. Acid decrystallization of aminopolysaccharides and derivatives thereof
US5547988B1 (en) 1986-12-23 1997-07-15 Tristrata Inc Alleviating signs of dermatological aging with glycolic acid lactic acid or citric acid
US5686489A (en) 1986-12-23 1997-11-11 Tristrata Technology, Inc. Alpha hydroxyacid esters for skin aging
US5091171B2 (en) 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
AU618517B2 (en) 1986-12-23 1992-01-02 Eugene J. Van Scott Additives enhancing topical actions of therapeutic agents
US4983382A (en) 1987-01-27 1991-01-08 Avon Products, Inc. Cosmetic preparation incorporating stabilized ascorbic acid
US5021451A (en) 1988-11-14 1991-06-04 Hoffman-La Roche Inc. Method for inhibiting hyperproliferative diseases
US5153230A (en) 1989-10-06 1992-10-06 Perfective Cosmetics, Inc. Topical skin cream composition
GB9003201D0 (en) 1990-02-13 1990-04-11 Unilever Plc Cosmetic composition
US5093109A (en) 1990-04-04 1992-03-03 Chanel, Inc. Cosmetic composition
US5290766A (en) 1991-02-18 1994-03-01 The National Heart Foundation Of New Zealand Cardioplegic compositions
ES2039336T3 (es) 1991-04-10 1999-08-01 Yu Ruey J Uso de composiciones cosmeticas que contienen acidos 2-hidroxicarboxilicos y compuestos afines para aliviar los indicios de cambios de las uñas.
FR2681863B1 (fr) 1991-09-27 1995-02-03 Rhone Dpc Europ Solution de sparfloxacine sa preparation et sel la constituant.
JP3082058B2 (ja) * 1992-05-22 2000-08-28 株式会社ホーネンコーポレーション ６−Ｏ−α−Ｄ−ガラクトピラノシル−Ｌ−アスコルビン酸またはその塩およびその製造法並びにその用途
JPH06263790A (ja) * 1993-03-12 1994-09-20 Unitika Ltd ２−Ｏ−β−Ｄ−ガラクトピラノシル−Ｌ−アスコルビン酸またはその塩およびその製造法並びにその用途
US5714163A (en) 1994-06-27 1998-02-03 Nexstar Pharmaceuticals, Inc. Vinca alkaloid vesicles with enhanced efficacy and tumor targeting properties
JPH08291192A (ja) * 1995-04-25 1996-11-05 Nippon Shokuhin Kako Co Ltd ラクトン化オリゴ糖、その製造方法及びα−アミラーゼ阻害剤
US5877212A (en) 1997-04-16 1999-03-02 Yu; Ruey J. Molecular complex and control-release of alpha hydroxyacids
US6159480A (en) * 1997-12-15 2000-12-12 Neostrata Company, Inc. Cosmetic makeup composition
US6335023B1 (en) * 1999-06-30 2002-01-01 Ruey J. Yu Oligosaccharide aldonic acids and their topical use

Also Published As

Publication number Publication date
JP4804018B2 (ja) 2011-10-26
WO2001001932A3 (en) 2001-05-17
ATE323498T1 (de) 2006-05-15
EP1227820A2 (en) 2002-08-07
CA2373852C (en) 2009-06-23
DE60027455T2 (de) 2006-12-14
US20020028227A1 (en) 2002-03-07
AU6335300A (en) 2001-01-22
DK1227820T3 (da) 2006-08-21
AU775620B2 (en) 2004-08-05
BR0011640B1 (pt) 2014-07-29
EP1227820B1 (en) 2006-04-19
MX249762B (es) 2007-10-01
JP4326737B2 (ja) 2009-09-09
PT1227820E (pt) 2006-08-31
JP2011140499A (ja) 2011-07-21
CN1635864A (zh) 2005-07-06
CY1105407T1 (el) 2010-04-28
BRPI0011640B8 (pt) 2021-05-25
CA2373852A1 (en) 2001-01-11
DE60027455D1 (de) 2006-05-24
CN1635864B (zh) 2010-06-16
ES2262529T3 (es) 2006-12-01
JP2005232180A (ja) 2005-09-02
HK1048764A1 (en) 2003-04-17
US6740327B2 (en) 2004-05-25
WO2001001932A2 (en) 2001-01-11
HK1048764B (en) 2006-09-15
MXPA01013042A (es) 2003-08-20
US6335023B1 (en) 2002-01-01
JP2003503436A (ja) 2003-01-28

Similar Documents

Publication Publication Date Title
BR0011640A (pt) ácidos aldÈnicos de oligossacarìdeo e seu uso tópico
US5324746A (en) Method of treating damaged mucosal and epithelial tissues with misoprostol
NO20044699L (no) Vaginalpleiesammensetning
BR0007430A (pt) Composição tópica compreendendo n-acetilaminoácidos ou n-acetilaldosaminas
Neena et al. An ancient herb aloevera in dentistry: A review
EP1444984B1 (en) Topical pharmaceutical compositions containing natural active constituents suitable for the prevention and treatment of mucosal inflammation processes
US5972906A (en) Treatment of mucous membrane disease, trauma or condition and for the relief of pain thereof
JP2016153436A (ja) 微生物感染の治療に使用するためのタマリンド種子多糖
Jain Clinical evaluation of 0.2% hyaluronic acid containing gel in the treatment of gingivitis
JP5981419B2 (ja) 炎症性疾患の治療に使用するためのタマリンド種子多糖
US4469702A (en) Analgesic composition and use thereof to ameliorate deep and intractable pain
US20220111119A1 (en) Host modulating and tissue regenerative hydrogel compositions and methods of their delivery to periodontal and peri-implant tissues
Shekhawat et al. Aloe vera-A miracle plant for dentistry
LeVan et al. The use of silicones in dermatology
Alghamdi et al. Topical Oxygen Therapy: A novel Strategy for Oral Healthcare
Jain et al. Herbs in periodontology–Local drug delivery
Arif et al. ESTHETIC MANAGEMENT OF PHENYTOIN INDUCED GINGIVAL ENLARGEMENT: GINGIVECTOMY FOLLOWED BY GINGIVOPLASTY
Dunn et al. Treatment options for psoriasis
Klingsberg et al. Comparative in vivo effects of enzymes on rodent periodontium
CN107854375A (zh) 一种消炎美白牙膏
CN108030727A (zh) 一种消炎止血牙膏
SHARMA REVIEWING DANTA GATA (DENTAL) VISHA CHIKITSA IN PRESENT DAY ORO-DENTAL DISEASES-AN AYURVEDA CONCEPT
CN107982142A (zh) 一种抑菌止血牙膏
Babu et al. Hyaluronic Acid Uses in Oral Health
CN107929158A (zh) 一种消炎美白止血牙膏

Legal Events

Date Code Title Description
B15K Others concerning applications: alteration of classification

Free format text: PARA:INT.CI. A61K 31/192, A61P 17/00, A61P 15/00

Ipc: A61K 31/192 (2006.01), A61P 17/00 (2006.01), A61P

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 29/07/2014, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 28/06/2000 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 28/06/2020